The impact of delayed adjuvant chemotherapy on survival in gastric cancer patients with and without preoperative chemotherapy
Abstract Aim Adjuvant chemotherapy (AC) is the standard treatment for patients with advanced gastric cancer (GC), yet the optimal timing for its initiation remains unclear. Besides, no studies have definitively established when AC should begin in patients receiving preoperative chemotherapy (PC). Th...
Saved in:
| Main Authors: | Masataka Shimonosono, Takaaki Arigami, Daisuke Matsushita, Yusuke Tsuruda, Ken Sasaki, Kenji Baba, Takao Ohtsuka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-07-01
|
| Series: | Annals of Gastroenterological Surgery |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ags3.12911 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Timing of postoperative chemotherapy and prognosis in neoadjuvant-treated gastric cancer patients: a multicenter real-world cohort study
by: Hua-Long Zheng, et al.
Published: (2025-12-01) -
Adjuvant chemotherapy for gastric cancer
by: I. P. Kolesnyk, et al.
Published: (2015-12-01) -
Adjuvant Chemotherapy May be Waived for Breast Cancer Nonresponders to Neoadjuvant Chemotherapy: A Population‐Based Large Cohort Study
by: Lixi Li, et al.
Published: (2025-05-01) -
Cervical Mesonephric Adenocarcinoma Treated with Neoadjuvant Chemotherapy: A Case Report and a Literature Review
by: Hiroaki Ishida, et al.
Published: (2024-11-01) -
Prognostic factors and adjuvant chemotherapy efficacy in stage I gastric cancer patients: a retrospective analysis
by: Hua Xiao, et al.
Published: (2024-12-01)